121 related articles for article (PubMed ID: 1686349)
21. The 2-chlorodeoxyadenosine-induced cell death signalling pathway in human thymocytes is different from that induced by 2-chloroadenosine.
Szondy Z
Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):585-8. PubMed ID: 7487899
[TBL] [Abstract][Full Text] [Related]
22. 2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA).
Gruber J; Geisen F; Sgonc R; Egle A; Villunger A; Boeck G; Konwalinka G; Greil R
Stem Cells; 1996 May; 14(3):351-62. PubMed ID: 8724701
[TBL] [Abstract][Full Text] [Related]
23. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
Carrera CJ; Terai C; Lotz M; Curd JG; Piro LD; Beutler E; Carson DA
J Clin Invest; 1990 Nov; 86(5):1480-8. PubMed ID: 1700795
[TBL] [Abstract][Full Text] [Related]
24. [Alpha interferon treatment in hairy cell leukemia].
Hagberg H
Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
[TBL] [Abstract][Full Text] [Related]
25. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD
J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801
[TBL] [Abstract][Full Text] [Related]
26. 2-Chlorodeoxyadenosine in the treatment of multiple myeloma.
Dimopoulos MA; Kantarjian HM; Estey EH; Alexanian R
Blood; 1992 Sep; 80(6):1626. PubMed ID: 1355673
[No Abstract] [Full Text] [Related]
27. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
[TBL] [Abstract][Full Text] [Related]
28. The treatment of hairy cell leukemia: an update.
Golomb HM; Ratain MJ; Mick R; Daly K
Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and induction of apoptosis in B cell chronic leukemia by diosgenyl 2-amino-2-deoxy-beta-D-glucopyranoside hydrochloride and its derivatives.
Myszka H; Bednarczyk D; Najder M; Kaca W
Carbohydr Res; 2003 Jan; 338(2):133-41. PubMed ID: 12526837
[TBL] [Abstract][Full Text] [Related]
30. Modulation of apoptosis in human lymphocytes by adenosine analogues.
Barbieri D; Franceschi C; Camaioni E; Costanzi S; Vittori S; Volpini R; Cristalli G
Bioorg Med Chem Lett; 1998 Sep; 8(18):2533-8. PubMed ID: 9873575
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia.
Beck FW; Eilender DS; Dandashi MH; Siddiq F; Snell DC; Godmere MA; Al-Katib AM; Mohammad RM
Int J Mol Med; 2004 Jul; 14(1):113-9. PubMed ID: 15202025
[TBL] [Abstract][Full Text] [Related]
32. Chronic B cell lymphocytic leukemias: diagnosis and cytologic characteristics of their cells.
Kitani T
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1279-86. PubMed ID: 2698043
[No Abstract] [Full Text] [Related]
33. Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells.
Zinzani PL; Martinelli G; Buzzi M; Farabegoli P; Bendandi M; Tura S
Haematologica; 1995; 80(4):390-1. PubMed ID: 7590510
[No Abstract] [Full Text] [Related]
34. 2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma.
Piro LD
Semin Hematol; 1993 Oct; 30(4 Suppl 6):28-30. PubMed ID: 7908756
[No Abstract] [Full Text] [Related]
35. From the Food and Drug Administration.
Nightingale SL
JAMA; 1992 May; 267(18):2445. PubMed ID: 1349355
[No Abstract] [Full Text] [Related]
36. BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
Zaja F; Di Loreto C; Amoroso V; Salmaso F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Mariuzzi L; Beltrami CA; Baccarani M
Leuk Lymphoma; 1998 Feb; 28(5-6):567-72. PubMed ID: 9613987
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of New Potential Lipophilic Co-Drugs of 2-Chloro-2'-deoxyadenosine (Cladribine, 2-CdA, Mavenclad®, Leustatin®) and 6-Azauridine (z
Knies C; Reuter H; Hammerbacher K; Bender E; Bonaterra GA; Kinscherf R; Rosemeyer H
Chem Biodivers; 2019 Mar; 16(3):e1800497. PubMed ID: 30614625
[TBL] [Abstract][Full Text] [Related]
38. The purine analogs--a therapeutic beauty contest.
Cheson BD
J Clin Oncol; 1992 May; 10(5):868-71. PubMed ID: 1349035
[No Abstract] [Full Text] [Related]
39. Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
Viens D; St-Hilaire E; Beauregard P; Dufresne J; Knecht H
Leuk Lymphoma; 2008 Jul; 49(7):1424-6. PubMed ID: 18452105
[No Abstract] [Full Text] [Related]
40. The purine analogs--a therapeutic beauty contest.
Cheson BD
J Clin Oncol; 1992 Mar; 10(3):352-5. PubMed ID: 1346799
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]